# QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead

> **NCT01733368** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 198 (actual)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01733368
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-08
- **Final completion:** 2016-08
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733368, "QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01733368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*